FDA clears GE MBI biopsy accessory

By AuntMinnie.com staff writers

November 27, 2016 -- GE Healthcare and molecular breast imaging developer Dilon Diagnostics announced the U.S. Food and Drug Administration (FDA) clearance of GE's molecular breast imaging (MBI) localization accessory for breast biopsy.

Dilon is the exclusive distributor of GE's Discovery NM750b molecular breast imaging system in North America. The system is designed to measure and image the distribution of selected single photon emission radioisotopes to aid in lesion evaluation. The MBI localization accessory complements the Discovery NM750b breast imaging system, which is designed to locate, in 3D, breast lesions using information from stereotactic pairs of 2D images.

The Discovery NM750b system and the breast biopsy accessory will be presented at RSNA 2016 in Chicago.

If you like this content, please share it with a colleague!

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:

MemberID or Email Address:

Do you have a AuntMinnie.com password?

No, I want a free membership.

Yes, I have a password:

Forgot your password?

View our privacy policy.